Industry Insights

31. Why Looking Beyond R-Values Yields Big Insulation Benefits 10/5/2021

    R-values are the received wisdom for evaluating thermal insulation efficiency however there are several inherent flaws in the arguments for R-values as a dominant measurement of insulation efficiency. It pays in many ways to cast off the ‘R-value blinkers’ and take a more holistic view of insulation performance, one that focuses on what the insulation is actually there for.

32. Facilitating Great Virtual Meetings During A Pandemic (Or Any Other Time) 3/20/2020

    Even before the global pandemic of the novel coronavirus, virtual meetings were on the rise, With a large percentage of people working from home, it's now a public health imperative. Here's how to facilitate a risk assessment, root cause investigation, or something similar via “virtual facilitation” with team members and subject matter experts scattered around the world.

33. How Do You Inspect Packaging Of Bottles, Cans And Cylinders? 5/13/2016

    To ensure the package is error free, progressive companies now use automated proofreading solutions throughout the design and printing of the package and label.

34. Technical Due Diligence Considerations For Multi-Site Biopharma Acquisitions 4/14/2022

    Part 1 of this 2-part article series shared considerations for standalone biopharma manufacturing facility acquisitions. This article, Part 2, shares considerations for multi-site acquisitions when the seller is manufacturing part or all its products in-house.

35. 2 Things Every Emerging Biopharma Needs To Know About Supply Chain 5/8/2020

    For clinicians on the front lines with potential effective therapies who are exploring how to develop new drug products, as well as development-stage companies looking to manage clinical supply chains and transform their organization for product launch, a basic framework is needed in order to integrate supply chain operation into a business strategy.

36. The Microbiome Market Boom: 4 Factors Biopharma Needs To Know 2/10/2020

    Investment in the microbiome category is increasing as VCs and biopharma companies make investments and establish partnerships with start-ups that are commercializing novel offerings in the space.

37. Drug Formulation Development: Quick Reference Guide 7/11/2022

    This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.

38. Reproducible Powder Testing 7/28/2011
    Reproducibility, measurement sensitivity, and the usefulness of an analysis are inextricably linked. If a technique or instrument exhibits poor reproducibility, then measurements are ‘noisy’ and only gross trends or differences can be detected. As the pharmaceutical industry strives for greater knowledge of its processes and products, this becomes increasingly limiting.
39. The Role Of CRISPR Cas9 Plasmids In Gene-Editing 12/12/2023

    Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.

40. Compliance: Framing Success Utilizing PIC/S And EU GMP 12/20/2023

    Explore the differences between the Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP Guide and the EU GMP Guides, and gain insight into the teamwork between the FDA, MHRA, and PIC/S.